InvestorsHub Logo
Followers 13
Posts 1239
Boards Moderated 0
Alias Born 05/04/2010

Re: None

Tuesday, 07/17/2012 7:17:36 AM

Tuesday, July 17, 2012 7:17:36 AM

Post# of 84953
some news today on CHRI...they're not just sitting around waiting for HBRM

China Health Resource Develops Revolutionary Migraine Medication...
SICHUAN, China, July 17, 2012 /PRNewswire-Asia/ -- China Health Resource, Inc. (CHRI) announced today the successful development of a revolutionary TCM migraine medication called Toufeng Migraine tablet. The medication has demonstrated an effective rate of 96.5% in clinical observations. The new product was developed utilizing the company's Dahurian Angelica (DAR) as one it's key ingredients.

According to the company's forecast, the world's major pharmaceutical markets (USA, France, Germany, Italy, Spain, Britain and Japan) for anti-migraine drug sales will grow from $2.86 billion in 2002 to over $5.6 billion by 2013. Unlike Toufeng Migraine tables, most available medications are pain killers and many have serious side effects or carry a risk of dependency and addiction.

"Toufeng Migraine tablets have proven effective in our tests. It is naturally derived from our trademarked Sichuan DAR. This new product has a strong export market demand with a potential for immeasurable health benefits. We expect this to provide tremendous economic growth for CHRI," says Jiayin Wang, Chairman and CEO of CHRI.

The company is now moving forward with the approval process world-wide and is working to develop and expand commercialization through strategic partnerships.